API | aprobarbital

aprobarbital Report issue

Small molecule Experimental

ChEMBL DrugBank Drug Central PubChem repoDB

Active Ingredient History

Aprobarbital is a barbiturate derivative. Aprobarbital have been used for the short-term treatment of insomnia and for routine sedation to relieve anxiety, tension, and apprehension however, barbiturates generally have been replaced by benzodiazepines. ^NCATS

Chemistry

SMILES: CC(C)C1(CC=C)C(=O)NC(=O)NC1=O
InChIKey: UORJNBVJVRLXMQ-UHFFFAOYSA-N
Mol. Mass: 210.2298
ALogP: 0.57 Partition coefficient
ChEMBL Molecule:
aprobarbital

More Chemistry

Pharmacology

Mechanisms of Action: Missing data
Multi-specific: Missing data
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

Indications (2)

Approved Indications (2)

Anxiety (approved 1927)

Sleep Initiation and Maintenance Disorders (approved 1927)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue